Structural factors affecting affinad-o53.2--a novel recombinant fusion protein combining the activities of trail/apo2l and sm
Pieczykolan JS1, Kubiński K, Masłyk M, Pawlak SD, Pieczykolan A, Rózga PK, Szymanik M, Gałązka M, Teska-Kamińska M, Żerek B, Bukato K, Poleszak K, Jaworski A, Strożek W, Świder R, Zieliński R.
http://f.adamed.com.pl/Imported/news-picture/Invest%20New%20Drugs.pdf